22 December 2022 | News
Additional funding bolstered by latest Series C1 financing round
image credit- Media Outreach
Doctor Anywhere (DA), a regional tech-led healthcare startup headquartered in Singapore, has acquired Catalist-listed Asian Healthcare Specialists, an integrated healthcare provider in Singapore.
Asian Healthcare Specialists is a group of 14 medical specialists, with a patient-first approach and vision to make specialised care accessible to all. Its 12 specialist clinics across multidisciplinary specialities comprise orthopaedics, ophthalmology, dermatology, urology, gastroenterology, otorhinolaryngology, anaesthesia, family medicine and rehabilitation – all areas that complement DA's regional healthcare services and offer consumers greater access to complex treatments.
The acquisition is a strategic step to further DA's long-term growth ambitions, enabling it to deliver more holistic healthcare and meet the rising demand for complex, specialised treatment across Southeast Asia.
Doctor Anywhere has also announced a $38.8 million Series C1 financing round, an up round led by Novo Holdings, a leading international life science investor. Other existing shareholders also participated in the round, including Asia Partners, Kamet Capital, Square Peg, IHH Healthcare, EDBI and OSK-SBI Venture Partners.
The funding will be used to accelerate growth and to partly fund the acquisition of Asian Healthcare Specialists.
Image caption- L-R: Travis Seet, Chief Finacial Officer (CFO) and Dr Chin Pak Lin, Chief Executive Officer (CEO) of Asian Healthcare Specialists; Lim Wai Mun, Founder & CEO and Edwin Basuki, CFO of Doctor Anywhere